Patents by Inventor Koji Ataka

Koji Ataka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130243736
    Abstract: In vitro 2-dimensional co-culture systems of LT-HSCs and osteoblastic niche cells and methods of establishing them are provided. For example, in certain aspects methods of screening people suffering from a disorder caused by dysfunction of osteoblastic niche cells, using said co-culture systems are described. In further aspects, methods for screening a candidate substance for treatment of a disorder caused by dysfunction of osteoblastic niche cells are provided. The present invention also concerns methods and therapeutic compositions of treating a patient suffering from a disorder caused by dysfunction of osteoblastic niche cells.
    Type: Application
    Filed: January 28, 2013
    Publication date: September 19, 2013
    Applicant: SAPPORO MEDICAL UNIVERSITY
    Inventors: Mineko Fujimiya, Koji Ataka, Hironori Chiba
  • Patent number: 6463424
    Abstract: There is provided a basic association unit for creating an information processing apparatus capable of performing information processing like information processing that actually occurs in central nerve systems of animals including human beings. The association unit is an unit for repeating input and output signals having m input terminals and n output terminals. When a first input signal which is a rectangular wave signal in the form of a pulse is simultaneously input to input terminals in a quantity less than m, an output signal having the same contents as the first input signal is output from particular output terminals which are associated with the input terminals in advance.
    Type: Grant
    Filed: April 23, 1998
    Date of Patent: October 8, 2002
    Inventors: Norio Ogata, Koji Ataka
  • Patent number: 6117913
    Abstract: An intestinal juice level regulator comprising, as the active ingredient, creosote or phenolic derivatives constituting creosote. As having the activities to promote the absorption of intestinal juices and/or to retard the secretion of intestinal juices, the active ingredient lowers the intestinal juice level in intestines. As the phenolic derivatives, usable are one or more of guaiacol, creosol, phenol, cresol and xylenol. The regulator is especially effective for retarding the hypersecretion of intestinal juices to be caused by heat-labile or heat-stable enterotoxin of enterotoxigenic Escherichia coli.
    Type: Grant
    Filed: June 19, 1997
    Date of Patent: September 12, 2000
    Assignee: Taiko Pharmaceutical Co., Ltd.
    Inventors: Akira Shibata, Takashi Shibata, Tomoo Kuge, Norio Ogata, Koji Ataka